Accéder au contenu
Merck

In vitro inhibition of cytochrome P450 3A4 by Aronia melanocarpa constituents.

Planta medica (2012-12-20)
Marie Bräunlich, Hege Christensen, Siri Johannesen, Rune Slimestad, Helle Wangensteen, Karl E Malterud, Hilde Barsett
RÉSUMÉ

Extracts, subfractions, isolated anthocyanins and procyanidins, and two phenolic acids from aronia [Aronia melanocarpa] were investigated for their CYP3A4 inhibitory effects, using midazolam as the probe substrate and recombinant insect cell microsomes expressing CYP3A4 as the enzyme source. Procyanidin B5 was a considerably stronger CYP3A4 inhibitor in vitro than the isomeric procyanidin B2 and comparable to bergamottin, a known CYP3A4 inhibitor from grapefruit juice. The inhibitory activity of proanthocyanidin-containing fractions was correlated to the degree of polymerization. Among the anthocyanins, cyanidin 3-arabinoside showed stronger CYP3A4 inhibition than cyanidin 3-galactoside and cyanidin 3-glucoside. Thus, the ability to inhibit CYP3A4 in vitro seems to be influenced by the sugar unit linked to the anthocyanidin.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Supelco
Bergamottin, analytical standard